Average Co-Inventor Count = 9.64
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (9 from 1,537 patents)
2. Padlock Therapeutics, Inc. (3 from 6 patents)
3. Genentech, Inc. (1 from 3,224 patents)
4. Ucb Biopharma Sprl (1 from 138 patents)
5. Apeiron Biologics Ag (1 from 15 patents)
6. Evotec Se (1 from 1 patent)
7. Evotec Ag (24 patents)
15 patents:
1. 11026937 - Heteroaryl inhibitors of PAD4
2. 10703741 - Covalent inhibitors of PAD4
3. 10472341 - Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases
4. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
5. 9963448 - Bicyclic inhibitors of PAD4
6. 9174980 - Heterocyclic compounds as inhibitors of leukotriene production
7. 9073895 - Biarylamide inhibitors of leukotriene production
8. 8901313 - 6,5-heterocyclic propargylic alcohol compounds and uses therefor
9. 8829200 - Benzimidazole inhibitors of leukotriene production
10. 8658661 - Oxadiazole inhibitors of leukotriene production
11. 8609696 - Serotonin 5-HT2B receptor inhibitors
12. 8580825 - Oxadiazole inhibitors of leukotriene production
13. 8580829 - Oxadiazole inhibitors of leukotriene production
14. 8575201 - Oxadiazole inhibitors of leukotriene production
15. 8420655 - Benzimidazole inhibitors of leukotriene production